Candidate

Study reveals candidate targets for anti-retroviral therapeutics

The increased frequency of drug resistance in isolates of the AIDS virus, HIV, makes identification of new antiviral targets an urgent necessity. Host genes required to support the replication of HIV are a potential source of such novel targets, but relatively few appropriate target genes have been identified in animal cells thus far. A new study, conducted by Dr. Suzanne Sandmeyer and colleagues...

New HIV drug candidate developed in Sweden

Which is more likely to happen - you being in a car wreck or being bitten by a shark? Those who answered that cars are greater killers win a free trip to the beach. It's really no contest, says a Texas A&M University professor. Your chances of being in a wreck are far greater than being a shark's lunch, says John McEachran, a professor of wildlife and fishery sciences who has studied...

Scientists identify a candidate gene for osteoporosis

Today, researchers report the identification of a gene that may play a role in susceptibility to osteoporosis—the crippling disease that leads to bone fractures, especially of the hip and spine. The study, conducted by scientists at the Musculoskeletal Diseases Center of the Jerry L Pettis Memorial Veteran's Affairs Medical Center at Loma Linda, shows convincing evidence that a gene called DAR...

U of S researchers develop new vaccine candidate against hepatitis C

Researchers at the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) have developed a vaccine candidate for hepatitis C, leading to hope in the fight against a disease for which no vaccines are yet available. VIDO is the first in Canada to show that this vaccination technique may be effective against HCV. The study was published in this month's Journal of Gene...

Candidate at Biology Products

No data found

Search Candidate biology products at Google

Search Candidate biology products at Yahoo

Search Candidate biology products at Msn

Candidate at Biology Technology

Tired of the spin? ExpertVoter website makes candidate selection easier

This election cycle may be the most democratic in modern history, thanks to blogs and other con...

What citizens don't ask political candidates

But when you spend time talking with ordinary citizens about problems tha...

Candidates' sparring over jobs focuses debate on right issue

how they would help turn around Milwaukee's economy. Beene, who had...

To find solid security candidates, look beyond tech certificates

As more organizations see security and compliance as their top issues, they dont see where security really fits on the organization chart. There is a big secret that few executives know about in most organizations: Security is a techie issue. It goes beyond knowing virus scans and firewalls. Security should be at an executive level because its a business strategy and not a low-level fu...

What to do when dining with a Jive Turkey technology job candidate

While theyre all true stories and authentic trends, wed hate to leave readers with the notion that its only managers who behave outrageously. So you know were not biased in our doling out of criticism, heres a story about a technology...

More>>

Candidate at Medicine News

Candidate vaccine to reduce hepatitis C viral load.

Hepatitis C virus is the leading cause of death and liver transplant in the western world. This disease is also very common that it is incidence is five times more when compared to HIV/ AIDS. // Hence researchers at the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) have developed a vaccine candidate to treat hepatitis C infection. This vaccine techniqu...

New Test Identifies Candidates For Cardiac Defibrillator

Several lives were saved in the US in 2005 from the fatal arrhythmias through devices which were surgically implanted in them. // As many as 1,70,000 people in North America received this treatment. Quite a few of the patients also found this to be uncomfortable, unnecessary, and even dangerous. A noninvasive test has been developed recently to find out which of the patients are likely to benefit...

HIV-Positive Woman To Be Congress Candidate In Assam

A 29-year-old HIV-positive woman in Assam is all set for a plunge into politics by becoming the ruling Congress party candidate for next month's assembly elections.// Jahnabi Goswami is expected to be the party's candidate from the Barhampur assembly constituency in eastern Assam's Nagaon district, about 140 km from here. Former Assam chief minister Prafulla Kumar Mahanta i...

Reservation For SC/ST Candidates Under 50% All India Quota

In the application filed before the Hon’ble Supreme Court, the Central Government proposed 15% reservation// to SCs and 7-1/2% to ST candidates in the All India Quota seats of Post Graduate medical/dental course admissions from the academic session 2007-08. While disposing of this application for directions filed by the Central Government in Buddhi Prakash Sharma case Vs Union of India, WP 18/200...

Republican Presidential Candidates Discuss Abortion, Stem Cells as Part of First Debate

Ten Republican presidential candidates on Thursday in their first televised debate -- held at the Ronald Reagan Presidential Library in Simi Valley , Calif. -- fielded questions about their views on abortion rights, stem cell research and other issues, the Washington Post reports. The 90-minute debate included Sens. John McCain (Ariz.) and Sam Brownback (Kan.); former New York Cit...

More>>

Candidate at Medicine Products

No data found

Search Candidate medicine products at Google

Search Candidate medicine products at Yahoo

Search Candidate medicine products at Msn

Candidate at Medicine Technology

Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate

FREISING-WEIHENSTEPHAN, Germany, July 10, 2007 /PRNewswire/ --Pieris AG, a bio-pharmaceutical company developing Anticalins(R), anovel class of targeted human protein therapeutics, today announcedsignificant progress in validating novel, effective products forthe potential treatment of asthma. In studies of its proprietaryPRS-060 Anticalin(R) candidate, the Company reports that theprotei...

CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 28, 2007 - CombinatoRx,Incorporated (NASDAQ: CRXX) today announced preliminary results ofits randomized, blinded, placebo-controlled clinical trial ofCRx-150 in patients with rheumatoid arthritis (RA). The trialcompared CRx-150 plus a disease-modifying anti-rheumatic drug(DMARD) to placebo plus DMARD (control) in subjects with active RA.In the prelimin...

Publication Confirms that EpCAM, the Target for Two of Micromet's Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers

BETHESDA, Md., June 26, 2007 /PRNewswire-FirstCall/ -- Micromet,Inc. , a biopharmaceutical company focusing on the development ofnovel, proprietary antibody-based products for cancer, inflammatoryand autoimmune diseases, announced that a study published recentlyin the Proceedings of the National Academy of Sciences (1) supportsthe findings of several other studies that EpCAM (CD326), whic...

Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection

SAN DIEGO, June 20, 2007 /PRNewswire-FirstCall/ -- AnadysPharmaceuticals, Inc. , a biopharmaceutical company committed tothe discovery, development and commercialization of novel medicinesfor the treatment of hepatitis and cancer, announced today that ithas nominated ANA598 as a candidate for clinical development as anorally-administered direct antiviral for the treatment of chronichepat...

Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 14, 2007 - CombinatoRx,Incorporated (NASDAQ: CRXX) today announced the presentation ofadditional data related to its immuno-inflammatory productcandidates, CRx-102 and CRx-139, at the European League AgainstRheumatism (EULAR) Annual Congress of Rheumatology meeting, June13-16, 2007 in Barcelona, Spain. In a poster entitled "Inhibition...

More>>